Chapter 1 Preface 8
1.1 Report Description 8
1.1.1 Purpose of the Report 8
1.1.2 Target Audience 8
1.1.3 USP and Key Offerings 8
1.2 Research Scope 9
1.3 Research Methodology 10
1.3.1 Phase I – Secondary Research 10
1.3.2 Phase II – Primary Research 11
1.3.3 Phase III – Expert Panel Review 11
1.3.4 Assumptions 12
Chapter 2 Executive Summary 13
2.1 Acquired Hemophilia Treatment Market Portraiture 13
2.2 Acquired Hemophilia Treatment Market, by Therapeutic Type, 2015 (US$ Mn) 14
2.3 Acquired Hemophilia Treatment Market, by Geography, 2015 (Value %) 15
Chapter 3 Global Acquired Hemophilia Treatment Market Analysis 16
3.1 Global Acquired Hemophilia Treatment Market Overview 16
3.2 Prevalence of Acquired Hemophilia 17
3.3 Market Dynamics 18
3.3.1 Market Drivers 18
3.3.1.1 Rise in Geriatric Population 18
3.3.1.2 Growing Demand for Prophylaxis Strategies 19
3.3.2 Challenges 20
3.3.2.1 Availability and Accessibility Constraints 20
3.3.3 Opportunities 21
3.4 Attractive Investment Proposition 21
3.5 Competitive Analysis: Global Acquired Hemophilia Treatment Market, 2015 (Value %) 22
Chapter 4 Global Acquired Hemophilia Treatment Market Analysis, By Type of Therapeutics 24
4.1 Preface 24
4.2 Traditional Therapy 24
4.3 Advanced Therapy 27
4.3.1 Desmopressin (DDAVP) 28
4.3.2 Recombinant Activated Factor VII/NovoSeven RT 30
4.3.3 Recombinant Porcine Factor VIII/Obizur 31
4.3.4 Activated Prothrombin Complex Concentrate (aPCC)/FEIBA 32
Chapter 5 Global Acquired Hemophilia Treatment Market, By Geography 34
5.1 Preface 34
5.1.1 Global Acquired Hemophilia Treatment Market, by Geography, 2014 – 2023 34
5.2 North America (U.S. & Canada) 35
5.3 Europe (U.K., Germany & Rest of Europe) 36
5.4 Asia Pacific (China, Japan, Singapore, South Korea and Rest of APAC) 38
5.5 Latin America (Mexico, Brazil and Rest of LATAM) 39
5.6 Middle East and Africa 40
Chapter 6 Company Profiles 42
6.1 Baxalta, Inc 42
6.2 Baxter Healthcare Corporation 43
6.3 Bristol-Myers Squibb 44
6.4 Genentech, Inc. 45
6.5 Novo Nordisk A/S 46
6.6 Ferring B.V. 47
6.7 Sanofi SA 49
List of Figures
FIG. 1 Acquired Hemophilia Treatment Market, Research Methodology 10
FIG. 2 Acquired Hemophilia Treatment Market, by Type of Device, 2015 (US$ Mn) 14
FIG. 3 Acquired Hemophilia Treatment Market, by Geography, 2015 (Value %) 15
FIG. 4 Attractive Investment Proposition 22
FIG. 5 Competitive Analysis: Global Acquired Hemophilia Treatment Market, 2015 (Value %) 23
FIG. 6 Desmopressin (DDAVP) Market (US$ Mn), 2013-2023 29
FIG. 7 Recombinant Activated Factor VII/NovoSeven RT Market (US$ Mn), 2013-2023 30
FIG. 8 Recombinant Porcine Factor VII/Obizur Market (US$ Mn), 2013-2023 31
FIG. 9 Activated Prothrombin Complex Concentrate (aPCC)/FEIBA Market (US$ Mn), 2013-2023 32
FIG. 10 Latin America (Mexico, Brazil and Rest of LATAM) Acquired Hemophilia Treatment Market (US$ Mn), 2013 – 2023 39
FIG. 11 Middle East & Africa Acquired Hemophilia Treatment Market (US$ Mn), 2013 – 2023 41
List of Tables
TABLE 1 Global Acquired Hemophilia Treatment Market, By Therapeutic Type (US$ Mn), 2013 – 2023 24
TABLE 2 Global Acquired Hemophilia Treatment Market, By Traditional Therapy (US$ Mn), 2013 – 2023 25
TABLE 3 Global Acquired Hemophilia Treatment Market, By Advanced Therapy (US$ Mn), 2013 – 2023 28
TABLE 4 Global Acquired Hemophilia Treatment Market (US$ Mn), by Geography, 2013 – 2023 34
TABLE 5 North America Acquired Hemophilia Treatment Market (US$ Mn), by Country, 2013 – 2023 36
TABLE 6 Europe Acquired Hemophilia Treatment Market (US$ Mn), by Country, 2013 – 2023 37
TABLE 7 Asia-Pacific Acquired Hemophilia Treatment Market (US$ Mn), by Country, 2013 – 2023 38
TABLE 8 Baxalta, Inc: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 42
TABLE 9 Baxter Healthcare Corporation: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage) 43
TABLE 10 Bristol-Myers Squibb: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage) 44
TABLE 11 Genentech, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage) 45
TABLE 12 Novo Nordisk A/S: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage) 46
TABLE 13 Ferring B.V.: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage) 47
TABLE 14 Sanofi SA: Company Snapshot (Business Description; Financial Performance; Product Position/Portfolio; News Coverage) 49